{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:21:21Z","timestamp":1787631681087,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"abstract":"<jats:p>\n                    Oral mucositis is a common complication in patients undergoing autologous hematopoietic stem cell transplantation (auto-HSCT), and currently, there is no universally effective treatment. This study aims to evaluate the preventive and delaying effects of oral cryotherapy using Kangfuxin (KFX) on oral mucositis in auto-HSCT patients. A total of 86 patients, treated between January 2020 and August 2023, were randomly assigned into 2 groups: the control group (40 cases) received cryotherapy using frozen physiological saline ice cubes, and the experimental group (46 cases) received KFX ice cubes. Both treatments started 30 minutes before melphalan infusion, and continued until the end of the infusion. The primary outcome was the incidence and severity of oral mucositis, with secondary outcomes including pain levels and patient-reported general condition. The experimental group demonstrated a significantly higher proportion of patients with grade 0 oral mucositis compared to the control group. Furthermore, the incidence of grade III\u2013IV oral mucositis in the control group was 32.5%, compared to 10.8% in the experimental group, showing a statistically significant difference (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). The experimental group had fewer days of using lidocaine mouthwash and lower pain scores, showing statistically significant differences (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). In conclusion, our findings suggest that KFX oral cryotherapy can be an effective approach for preventing and reducing the severity of oral mucositis in patients undergoing auto-HSCT. It may help alleviates the symptoms such as pain and discomfort, thereby improving patient well-being during treatment.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000042867","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T16:00:34Z","timestamp":1751904034000},"page":"e42867","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Oral cryotherapy by Kangfuxin for prophylaxis of oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation"],"prefix":"10.1097","volume":"104","author":[{"given":"Dan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-fang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-mei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-mei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-qiong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-miao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-hua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-0004","authenticated-orcid":false,"given":"Hao","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-266X","authenticated-orcid":false,"given":"Hai","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Hematology, People\u2019s Liberation Army The General Hospital of Western Theater Command, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250707","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.23.01159","article-title":"Patient-specific measurable residual disease markers predict outcome in patients with myelodysplastic syndrome and related diseases after hematopoietic stem-cell transplantation.","volume":"42","author":"J\u00e4dersten","year":"2024","journal-title":"J Clin Oncol"},{"key":"R2-20250707","doi-asserted-by":"crossref","first-page":"e919","DOI":"10.1016\/S2352-3026(22)00293-9","article-title":"Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions.","volume":"9","author":"Chang","year":"2022","journal-title":"Lancet Haematol"},{"key":"R3-20250707","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.3390\/jcm10245790","article-title":"Oral mucositis association with periodontal status: a retrospective analysis of 496 patients undergoing hematopoietic stem cell transplantation.","volume":"10","author":"Radochov\u00e1","year":"2021","journal-title":"J Clin Med"},{"key":"R4-20250707","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/antiox11101949","article-title":"Supplementation with oral vitamin C prior to and during myeloablative chemotherapy and autologous haematopoietic stem cell transplantation: a pilot study.","volume":"11","author":"Carr","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"R5-20250707","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JOP.19.00652","article-title":"Management of cancer therapy-associated oral mucositis.","volume":"16","author":"Brown","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"R6-20250707","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12903-022-02586-4","article-title":"Prevention and the treatment of oral mucositis: the efficacy of sodium bicarbonate vs other agents: a systematic review.","volume":"23","author":"Di Fede","year":"2023","journal-title":"BMC Oral Health"},{"key":"R7-20250707","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/curroncol30010074","article-title":"Interventions for the prevention of oral mucositis in patients receiving cancer treatment: evidence from randomised controlled trials.","volume":"30","author":"Colella","year":"2023","journal-title":"Curr Oncol"},{"key":"R8-20250707","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jamaoncol.2016.2680","article-title":"Oral cryotherapy for preventing oral mucositis in patients receiving cancer treatment.","volume":"2","author":"Riley","year":"2016","journal-title":"JAMA Oncol"},{"key":"R9-20250707","doi-asserted-by":"crossref","first-page":"8692343","DOI":"10.1155\/2016\/8692343","article-title":"Effect of kangfuxin solution on chemo\/radiotherapy-induced mucositis in nasopharyngeal carcinoma patients: a multicenter, prospective randomized phase III clinical study.","volume":"2016","author":"Luo","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"R10-20250707","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2021\/9973539","article-title":"Treatment of Yunnan Baiyao plus Kangfuxin solution reduces inflammatory response and prevents patients with nasopharyngeal carcinoma against radiation-induced oral mucositis.","volume":"2021","author":"Tang","year":"2021","journal-title":"J Nanomater"},{"key":"R11-20250707","first-page":"6792","article-title":"Efficacy of kangfuxin liquid on radiotherapy-induced oral mucositis for patients with head and neck squamous cell carcinoma and its effect on salivary glands and immune function.","volume":"14","author":"Yuan","year":"2022","journal-title":"Am J Transl Res"},{"key":"R12-20250707","doi-asserted-by":"crossref","first-page":"100693","DOI":"10.1016\/j.imu.2021.100693","article-title":"Effect and mechanism of Kangfuxin liquid on oral ulcer in patients with chemotherapy treated hematologic malignancies: Network pharmacology study and clinical observations.","volume":"25","author":"Bo","year":"2021","journal-title":"Inf Med Unlocked"},{"key":"R14-20250707","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bmt.1705384","article-title":"A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.","volume":"37","author":"Lilleby","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R15-20250707","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40168-019-0679-5","article-title":"Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.","volume":"7","author":"Hong","year":"2019","journal-title":"Microbiome"},{"key":"R16-20250707","doi-asserted-by":"crossref","first-page":"e2308439","DOI":"10.1002\/advs.202308439","article-title":"Salivary amylase-responsive buccal tablets wipe out chemotherapy-rooted refractory oral mucositis.","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"R17-20250707","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41385-019-0132-x","article-title":"Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis.","volume":"12","author":"Im","year":"2019","journal-title":"Mucosal Immunol"},{"key":"R18-20250707","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.3390\/ijms24098188","article-title":"Pathogenesis of oral toxicities associated with targeted therapy and immunotherapy.","volume":"24","author":"Villa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R19-20250707","doi-asserted-by":"crossref","first-page":"16314","DOI":"10.3390\/ijms242216314","article-title":"The role of the innate immune response in oral mucositis pathogenesis.","volume":"24","author":"Bowen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R20-20250707","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/0022034520925421","article-title":"Oral mucositis: an update on innate immunity and new interventional targets.","volume":"99","author":"Chen","year":"2020","journal-title":"J Dent Res"},{"key":"R21-20250707","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1007\/s00520-022-07361-3","article-title":"Oncology nursing practices in the management of chemotherapy-related oral mucositis in accordance with evidence-based guidelines: a descriptive and cross-sectional study.","volume":"30","author":"Gundogdu","year":"2022","journal-title":"Support Care Cancer"},{"key":"R22-20250707","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/10837450.2016.1221424","article-title":"Nystatin and lidocaine pastilles for the local treatment of oral mucositis.","volume":"22","author":"Silva","year":"2017","journal-title":"Pharm Dev Technol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:30:26Z","timestamp":1786041026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":21,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042867","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}